18,562 Shares in Compass Therapeutics, Inc. (NASDAQ:CMPX) Acquired by BNP Paribas Financial Markets
BNP Paribas Financial Markets acquired a new position in Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 18,562 shares of the company’s stock, valued at approximately $27,000. Several other institutional investors also recently modified their […]
BNP Paribas Financial Markets acquired a new position in Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 18,562 shares of the company’s stock, valued at approximately $27,000. Several other institutional investors also recently modified their […]
